Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125008713 | 12500871 | 3 | F | 20160615 | 20160714 | 20160627 | 20160721 | EXP | US-BIOGEN-2016BI00255838 | BIOGEN | 57.02 | YR | F | Y | 66.28000 | KG | 20160721 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125008713 | 12500871 | 1 | PS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 2 | SS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 3 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 4 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 6 | C | BONIVA | IBANDRONATE SODIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 7 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125008713 | 12500871 | 10 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125008713 | 12500871 | 1 | Multiple sclerosis |
| 125008713 | 12500871 | 3 | Product used for unknown indication |
| 125008713 | 12500871 | 4 | Product used for unknown indication |
| 125008713 | 12500871 | 5 | Product used for unknown indication |
| 125008713 | 12500871 | 6 | Product used for unknown indication |
| 125008713 | 12500871 | 7 | Product used for unknown indication |
| 125008713 | 12500871 | 8 | Product used for unknown indication |
| 125008713 | 12500871 | 9 | Product used for unknown indication |
| 125008713 | 12500871 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125008713 | 12500871 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125008713 | 12500871 | Asthenia | |
| 125008713 | 12500871 | Death | |
| 125008713 | 12500871 | Fatigue | |
| 125008713 | 12500871 | Temperature intolerance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125008713 | 12500871 | 1 | 20111025 | 20140731 | 0 | |
| 125008713 | 12500871 | 2 | 20151230 | 0 |